Welcome to our dedicated page for Kkr & Co SEC filings (Ticker: KKRT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Kkr & Co's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Kkr & Co's regulatory disclosures and financial reporting.
KKR & Co. Inc. insider reports a charitable stock donation and updated holdings. A reporting person who is a director and Co-Executive Chairman of KKR reported the donation of 350,000 shares of common stock on 11/12/2025. The shares were donated by a limited partnership controlled by the insider to a charitable foundation in which the insider has no pecuniary interest, and the partnership continues to hold additional shares for future donations. Following this transaction, the insider reports beneficial ownership of 5,460,000 shares indirectly through the partnership, 73,006,022 shares directly, and additional indirect holdings of 1,549,369, 1,000,000, and 15,227 shares through other entities and the insider’s spouse. The insider states that beneficial ownership of indirectly held securities is disclaimed except to the extent of any pecuniary interest.
KKR & Co. Inc. furnished an earnings release announcing financial results for the quarter and nine months ended September 30, 2025. The release is provided as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition).
Consistent with Form 8‑K General Instruction B.2, the information in Item 2.02 and Exhibit 99.1 is furnished, not filed, and is not incorporated by reference into Securities Act or Exchange Act filings unless specifically referenced.